Skip to main content
. 2022 Jun 22;14(6):e26194. doi: 10.7759/cureus.26194

Table 1. Characteristics of included studies.

Inj.: injection; IV: intravenous.

Source Groups Number of participants Dose of drug Surgical procedure
Anjum et al. (2019) [12] D 30 Inj. dexmedetomidine 1 µg/kg IV Elective neurosurgical procedures
F 30 Inj. fentanyl 2 µg/kg iv
Arif et al. (2017) [13] D 24 Inj. dexmedetomidine 0.75 µg/kg IV Elective surgical procedure
F 24 Inj. fentanyl 2 µg/kg IV
Garg et al. (2020) [14] D 50 Inj. dexmedetomidine 1 µg/kg IV Elective surgical procedure
F 50 Inj. fentanyl 2 µg/kg IV
Gauchan et al. (2019) [15] D 30 Inj. dexmedetomidine 1 µg/kg IV Elective surgical procedure
F 30 Inj. fentanyl 2 µg/kg IV
Gunalan et al. (2015) [16] D 30 Inj. dexmedetomidine 1 µg/kg IV Elective surgical procedure
F 30 Inj. fentanyl 2 µg/kg IV
Mahiswar et al. (2022) [17] D 50 Inj. dexmedetomidine 0.5 µg/kg IV Elective surgical procedure
F 50 Inj. fentanyl 2 µg/kg IV
Mahjoubifard et al. (2020) [18] D 30 Inj. dexmedetomidine 1 µg/kg IV Elective cardiac surgery
F 30 Inj. fentanyl 2 µg/kg IV
Vaswani et al. (2017) [11] L 30 1.5 mg/kg intravenous lidocaine
D 30 Inj. dexmedetomidine 0.5 µg/kg IV Elective laparotomy
F 30 Inj. fentanyl 0.5 µg/kg IV